Monoclonal Antibodies to the Thyrotropin Receptor
Open Access
- 1 January 2005
- journal article
- review article
- Published by Hindawi Limited in Clinical and Developmental Immunology
- Vol. 12 (2) , 137-143
- https://doi.org/10.1080/17402520500078238
Abstract
The thyrotropin receptor (TSHR) is a seven transmembrane G-protein linked glycoprotein expressed on the thyroid cell surface and which, under the regulation of TSH, controls the production and secretion of thyroid hormone from the thyroid gland. This membrane protein is also a major target antigen in the autoimmune thyroid diseases. In Graves' disease, autoantibodies to the TSHR (TSHR-Abs) stimulate the TSHR to produce thyroid hormone excessively. In autoimmune thyroid failure, some patients exhibit TSHR-Abs which block TSH action on the receptor. There have been many attempts to generate human stimulating TSHR-mAbs, but to date, only one pathologically relevant human stimulating TSHR-mAb has been isolated. Most mAbs to the TSHR have been derived from rodents immunized with TSHR antigen from bacteria or insect cells. These antigens lacked the native conformation of the TSHR and the resulting mAbs were exclusively blocking or neutral TSHR-mAbs. However, mAbs raised against intact native TSHR antigen have included stimulating mAbs. One such stimulating mAb has demonstrated a number of differences in its regulation of TSHR post-translational processing. These differences are likely to be reflective of TSHR-Abs seen in Graves' disease.Keywords
Funding Information
- National Institutes of Health (DK52464, DK45011, AI24671)
This publication has 56 references indexed in Scilit:
- Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptorClinical and Experimental Immunology, 2004
- Levels of Autoantibodies against Human TSH Receptor Predict Relapse of Hyperthyroidism in Graves’ DiseaseHormone and Metabolic Research, 2004
- Generation of a transgenic animal model of hyperthyroid Graves' diseaseEuropean Journal of Immunology, 2003
- Ligand-dependent Inhibition of Oligomerization at the Human Thyrotropin ReceptorJournal of Biological Chemistry, 2002
- Epitope Analysis of the Human Thyrotropin (TSH) Receptor Using Monoclonal AntibodiesThyroid®, 2000
- The Prevalence and Clinical Significance of Blocking Thyrotropin Receptor Antibodies in Untreated Hyperthyroid Graves' DiseaseThyroid®, 2000
- Second Generation Assay for Thyrotropin Receptor Antibodies Has Superior Diagnostic Sensitivity for Graves' DiseaseJournal of Clinical Endocrinology & Metabolism, 1999
- Characterization of Monoclonal Thyroid-Stimulating and Thyrotropin Binding-Inhibiting Autoantibodies from a Hashimoto's Patient Whose Children Had Intrauterine and Neonatal Thyroid DiseaseJournal of Clinical Endocrinology & Metabolism, 1997
- Thyrotropin Receptor Autoantibodies in Serum Are Present at Much Lower Levels Than Thyroid Peroxidase Autoantibodies: Analysis by Flow CytometryJournal of Clinical Endocrinology & Metabolism, 1997
- Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cellsJournal of Molecular Endocrinology, 1996